A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

Journal of Bone and Mineral Research

Volumn 11, Issue 2, 1996, Pages 150-159

  Parfitt, A M ^a,c   Mundy, G R ^b   Roodman, G D ^b   Hughes, D E ^b   Boyce, B F ^b  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CYTOKINE; ESTROGEN; INTERLEUKIN 1; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; BONE REMODELING; CANCELLOUS BONE; CORTICAL BONE; DRUG EFFECT; HUMAN; HUMAN CELL; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; REGULATORY MECHANISM; REVIEW;

EID: 0030039250     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110203     Document Type: Review

References (70)

1. Parfitt AM 1994 Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 55:273-286.
2. Parfitt AM 1996 Skeletal heterogeneity and the purposes of bone remodelling: implications for the understanding of osteoporosis. In: Marcus R, Feldman B, Kelsey J (eds.) Osteoporosis. Academic Press: San Diego (in press).
3. Fleisch H 1993 Bisphosphonates in bone disease. From the Laboratory to the Patient. Stampfli & Co. Ltd., Berne, Switzerland.
4. Storm T, Steiniche T, Thamsborg G, Meisen F 1993 Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for post-menopausal osteoporosis. J Bone Miner Res 8:199-208.
5. Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D, Quartuccio H, Fioravanti C, Clair J, Brown E, Haves WC, Rodan GA 1993 The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577-2586.
6. Smith ML, Fogelman I, Hart DM, Scott E, Bevan J, Leggate I 1989 Effect of etidronate disodium on bone turnover following surgical menopause. Calcif Tissue Int 44:74-79.
7. Passeri M, Baroni MC, Pedrazzoni M, Pioli G, Barbagallo M, Costi D, Biondi M, Girasole G, Arlunno B, Palummeri E 1991 Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1, 1-bisphosphonate (AHBUBP) in the therapy of post-menopausal osteoporosis. Bone Miner 15:237-247.
8. Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC 1990 Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 85:456-461.
9. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson D, Golub E, Rodan G 1991 Bisphosphonate action: Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095-2105.
10. Piper K, Boyde A, Jones SJ 1994 The effect of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD) on the resorptive function of osteoclasts of known nuclear number. Calcif Tissue Int 54:56-61.
11. Marshall MJ, Holt I, Davie MWJ 1993 Osteoclast recruitment in mice is stimulated by 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate. Calcif Tissue Int 52:21-25.
12. Evans CE, Braidman IP 1994 Effects of two novel bisphosphonates on bone cells in vitro. Bone Miner 26:95-107.
13. Frost HM 1973 Bone Remodeling and Its Relationship to Metabolic Bone Diseases. Charles C Thomas, Springfield, Illinois.
14. Parfitt AM 1990 Pharmacologic manipulation of bone remodelling and calcium homeostasis. In: Kanis JA (ed.) Progress in Basic and Clinical Pharmacology, Vol 4, Calcium Metabolism. S. Karger, Basel, Switzerland, pp. 1-27.
15. Parfitt AM 1993 Morphometry of bone resorption: Introduction and overview. Bone 14:435-441.
16. Eriksen EF 1986 Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocrinol Rev 4:379-408.
17. Yamaguchi K, Croucher PI, Compston JE 1993 Comparison between the lengths of individual osteoid seams and resorption cavities in human iliac cancellous bone. Bone Miner 23:27-33.
18. Parfitt AM 1976 The actions of parathyroid hormone on bone. Relation to bone remodelling and turnover, calcium homeostasis and metabolic bone disease. I. Mechanisms of calcium transfer between blood and bone and their cellular basis. Morphologic and kinetic approaches to bone turnover. Metabolism 25:809-844.
19. Martin RB 1994 On the histologic measurement of osteonal BMU activation frequency. Bone 15:547-549.
20. Parfitt AM 1990 Bone-forming cells in clinical conditions. In: Hall BK (ed.) Bone: A Treatise, Vol. 1, The Osteoblast and Osteocyte. Telford Press, Caldwell, New Jersey, pp. 351-429.
21. Peck WA, Woods WL 1988 The cells of bone. In: Riggs BL, Melton III LJ (eds.) Osteoporosis: Etiology, Diagnosis, and Management. Raven Press, New York, pp. 1-44.
22. Parfitt AM 1983 The physiologic and clinical significance of bone histomorphometric data. In: Recker R (ed.) Bone Histomorphometry: Techniques and Interpretations. CRC Press, Boca Raton, Florida, pp. 143-223.
23. Jaworski ZFG 1992 Haversian systems and haversian bone. In: Hall BK (ed.) Bone Metabolism and Mineralization. Vol IV. CRC Press, Boca Raton, Florida, pp. 21-45.
24. Hancox NM 1972 Biology of Bone. Cambridge University Press, Cambridge.
25. Rasmussen H, Bordier P 1974 The Physiological and Cellular Basis of Metabolic Bone Disease. Williams & Wilkins Co., Baltimore, Maryland.
26. Heersche JNM 1989 Bone cells and bone turnover - the basis for pathogenesis. In: Tam CS, Heersche JNM, Murray TM (eds.) Metabolic Bone Disease: Cellular and Tissue Mechanisms. CRC Press, Boca Raton, Florida, pp. 1-17.
27. Kerr JFR, Wyllie AH, Currie AR 1972 Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
28. Wytlie AH, Kerr JFR, Currie AR 1980 Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.
29. Lockshin RA, Beaulaton J 1974 Programmed cell death. Life Sci 15:1549-1565.
30. Schwartzman RA, Cidlowski JA1993 Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocrinol Rev 14:133-151.
31. Wright KR, Hughes DH, Guise TA, Boyle IT, Devlin R, Windle J, Roodman GD, Mundy GR, Boyce BF 1994 Osteoclasts undergo apoptosis at the interface between resorption and formation in bone remodelling units. J Bone Miner Res 9 (Suppl 1):S174.
32. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF 1995 Bisphosphonates promote aptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487.
33. Baserga R (ed.) 1985 The Biology of Cell Reproduction. Harvard University Press, Cambridge, Massachusetts.
34. Hughes DE, Wright KR, Mundy GR, Boyce BF 1994 TGF-β1 induces osteoclast apoptosis in vitro. J Bone Miner Res 9 (Suppl 1):S138.
35. Takada Y, Baylink DJ, Linkhart T, Edwall D, Kumegawa M, Mohan S 1994 Calcitropic hormones and growth factors regulate osteoclast survival in vitro. J Bone Miner Res 9 (Suppl 1):S311.
36. Bonewald LF, Mundy GR 1990 Role of transforming growth factor beta in bone remodeling. Clin Orthop Rel Res 250:261-276.
37. Jaworski ZF. Lok E 1972 The rate of osteoclastic bone erosion in haversian remodeling sites of adult dog's rib. Calcif Tissue Res 10:103-112.
38. Chambers TJ 1980 The cellular basis of bone resorption. Clin Orthop Rel Res 151:283-293.
39. Skjodt H, Russell G 1992 Bone cell biology and the regulation of bone turnover. In: Gowen M (ed.) Cytokines and Bone Metabolism. CRC Press, Boca Raton, Florida, pp. 1-70.
40. Lanyon LE 1992 The success and failure of the adaptive response to functional load-bearing in averting bone fracture. Bone 13:S17-S21.
41. Parfitt AM 1995 Problems in the application of in vitro systems to the study of human bone remodeling. Proceedings from the Workshop on Human Models of Skeletal Aging, NIH, February, 1994. Calcif Tissue Int 56 (Suppl 1):S5-S7.
42. Mundy GR, Poser JW 1983 Chemotactic activity of the γ-carboxyglutamic acid containing protein in bone. Calcif Tissue Int 35:164-168.
43. Melsen F, Mosekilde L, Eriksen EE 1995 Spatial distribution of sinusoids in relation to remodeling sites: Evidence for specialized sinusoidal structures associated with formative sites. J Bone Miner Res 10 (Suppl):S209.
44. Brieland JK, Flory CM, Jones ML, Miller GR, Remick DG, Warren JS, Fantone JC 1995 Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide. tumor necrosis factor-α, and interleukin-1β. Am J Resp Cell Mol Biol 12:104-109.
45. Roodman GD, Kurihara N, Ohsaki Y, Kukita T, Hosking D, Demulder A, Singer FR 1992 Interleukin-6: A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 89:46-52.
46. Takahashi S, Reddy SV, Chirgwin JM, Devlin R, Baipek C, Anderson J, Roodman GD 1994 Cloning and identification of Annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem 269: 28696-28701.
47. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. New Engl J Med 332:305-311.
48. Reddy SV, Takahashi S, Dallas M, Williams RE. Neckers L, Roodman GD 1994 Inter-leukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone. J Bone Miner Res 9:753-757.
49. Suarez F, Rothhut B, Cornera C Touqui L, Marie FR, Silve C 1993 Expression of annexin I, II, V, and VI by rat osteoblasts in primary culture: stimulation of annexin I expression by dexamethasone. J Bone Miner Res 8:1201-1210.
50. Yeatman TJ, Updyke TV, Kaetzel MA, Dedman JR, Nicolson GL 1993 Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin Exp Metastasis 11:37-44.
51. Nesbitt SA, Henzel W, Horton MA 1994 Biochemical characterization of annexin expression on the human osteoclast membrane. Bone Miner 25 (abstract):S48.
52. Metcalf D 1988 The Molecular Control of Blood Cells. Harvard University Press, Cambridge, Massachusetts.
53. Vaux DL, Haecker G, Strasser A 1994 An evolutionary perspective on apoptosis. Cell 76:777-779.
54. Thornberry NA 1994 Key mediator takes shape. Nature 370: 251-252.
55. Parfitt AM 1995 Bone remodeling, normal and abnormal: A biological basis for the understanding of cancer-related bone disease and its treatment. Can J Oncol (in press).
56. Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ 1993 Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 91:2004-2011.
57. Vitte C, Fleisch H, Guenther HL 1994 Osteoblasts mediate the bisphosphonate inhibition on bone resorption through synthesis of an osteoclast-inhibiting activity. J Bone Miner Res 9 (Suppl):S142.
58. Passeri G, Girasole G, Ulietti V, Giuliani N, Pedrazzoni M, Sartori L, Jilka RL, Manolagas SC 1994 Bisphosphonates inhibit IL-6 production by human osteoblast cells MG-63. J Bone Miner Res 9 (Suppl):S230.
59. Hughes DE. MacDonald BR, Russell RGG, Gowen M 1989 Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow, J Clin Invest 83:1930-1935.
60. Boyce RW, Paddock CL, Gleason JR, Sletsema WK, Eriksen EF 1995 The effects of risedronate on canine cancellous bone remodeling: Three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res 10:211-221.
61. Parfitt AM 1992 The physiologic and pathogenetic significance of bone histomorpho-metric data. In: Coe FL, Favus MJ (eds.) Disorders of Bone and Mineral Metabolism. Raven Press, New York, pp. 475-489.
62. Mosekilde L, Weisbrode SE, Safron JA, et al 1993 Calcium-restricted ovariectomized Sinclair S-1 minipigs: An animal model of osteopenia and trabecular plate perforation. Bone 14:379-382.
63. Dempster DW, Li X-E, Birchman R, Shen V, Lindsay R 1991 Temporal changes in trabecular structure following ovariectomy in rats. J Bone Miner Res 6 (Suppl):S224.
64. Hughes DE, Wiltschke K, Mundy GR, Boyce BF 1995 Estrogen promotes osteoclast apoptosis in vitro and in vivo. Bone 16 (Suppl 1):93S.
65. Azria M 1989 The Calcitomns: Physiology and Pharmacology. S. Karger, Basel, Switzerland.
66. Mundy GR, Roodman GD, Osteoclast ontogeny and function. In: Reck WA (ed.) Bone and Mineral Research, Vol 5, Elsevier, Amsterdam, pp. 209-279.
67. Hughes DE, Wright KR, Sasaki A, Yoneda T, Uy H, Roodman GD. Mundy GR, Boyce BF 1994 Bisphosphonates induce osteoclast apoptosis in vivo and in vitro, but calcitonin does not. J Bone Miner Res 9 (Suppl 1):S347.
68. Reginster JYL 1993 Calcitonins: Newer routes of delivery. Osteoporosis Int 3 (Suppl 2):S3-S7.
69. Boyce RW, Bouchard GF, Paddock CL, et al. 1995 Effects of Calcimar on vertebral cancellous bone in ovariectomized Sinclair minipgs: Evidence for blunting of resorptive cell activity with increased bone turnover. Abstract T390. J Bone Miner Res 10 (Suppl 1):S452.
70. Eriksen EF, Steiniche T, Mosekilde L, Melsen F 1989 Histomorphometric analysis of bone in metabolic bone disease. Endocrinol Metab Clin N Am 18:919-954 .